Story perspectives

Danaher Reports Strong Q4, But 2026 Guidance Worries Investors

1/28/2026

Summary

Story summary

Danaher Corporation (NYSE:DHR) reported Q4 2025 revenue of $6.84 billion.
Adjusted earnings per share rose to $2.23 and beat estimates by 1.8%.
Danaher's stock declined as investors questioned the company's 2026 guidance.
Analysts project low-single-digit core revenue growth for 2026, with anticipated improvements in bioprocessing and diagnostics.
The company maintains a strong market capitalization, but return on equity remains below industry averages.

History

Historical Context

The 2008 global financial crisis caused a 38.5% drop in the S&P 500, severely impacting companies like Danaher Corporation. This downturn forced firms to adapt to economic volatility. Today, Danaher reports Q4 2025 revenue of $6.84 billion, reflecting ongoing challenges and low-single-digit growth predictions for 2026, highlighting the need for strategic planning in the bioprocessing and diagnostics sectors.

1 of 2

Story summary

Danaher Corporation (NYSE:DHR) reported Q4 2025 revenue of $6.84 billion.
Adjusted earnings per share rose to $2.23 and beat estimates by 1.8%.
Danaher's stock declined as investors questioned the company's 2026 guidance.
Analysts project low-single-digit core revenue growth for 2026, with anticipated improvements in bioprocessing and diagnostics.
The company maintains a strong market capitalization, but return on equity remains below industry averages.

1 / 2